Viewing Study NCT01423903


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-06-04 @ 6:07 PM
Study NCT ID: NCT01423903
Status: COMPLETED
Last Update Posted: 2014-01-15
First Post: 2011-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None STAT-3 inhibitor View
None solid tumors View